Bayanan asali
Sunan samfur | Katalogi | Nau'in | Mai watsa shiri/Madogararsa | Amfani | Aikace-aikace | COA |
HCV Core-NS3-NS5 fusion antigen | BMGHCV101 | Antigen | Ecoli | Kama | LF, IFA, IB, WB | Zazzagewa |
HCV Core-NS3-NS5 fusion antigen | BMGHCV102 | Antigen | Ecoli | Conjugate | LF, IFA, IB, WB | Zazzagewa |
Yawancin marasa lafiya ba su da alamun bayyanar cututtuka a cikin mummunan mataki na kamuwa da cuta, tare da manyan matakan viremia da hawan ALT.HCV RNA ya bayyana a cikin jini a baya fiye da anti HCV bayan kamuwa da cutar HCV mai tsanani.HCV RNA za a iya gano 2 makonni bayan fallasa da farko, HCV core antigen za a iya gano 1 zuwa 2 kwanaki bayan HCV RNA bayyana, da anti HCV ba za a iya gano har sai 8 zuwa 12 makonni, wato, bayan HCV kamuwa da cuta, akwai game da 8-12 makonni, HCV RNA ne kawai za a iya gano, yayin da HCV RNA ne kawai za a iya gano, yayin da anti HCV da tsawon lokaci ne anti HCV. “Lokacin taga” yana da alaƙa da reagent na ganowa (duba Table 1).Anti HCV ba maganin rigakafi ba ne, amma alamar kamuwa da cutar HCV.15% ~ 40% na marasa lafiya tare da m HCV kamuwa da cuta iya share kamuwa da cuta a cikin watanni 6.A cikin aiwatar da kawar da kamuwa da cuta, matakin HCV RNA na iya yin ƙasa da ƙasa ba za a iya gano shi ba, kuma anti HCV kawai yana da inganci;Koyaya, 65% ~ 80% na marasa lafiya ba a share tsawon watanni 6 ba, wanda ake kira kamuwa da cutar HCV na yau da kullun.Da zarar ciwon hanta na C na kullum ya faru, HCV RNA titer ya fara daidaitawa, kuma farfadowa na gaggawa yana da wuya.Sai dai idan ba a gudanar da ingantaccen maganin rigakafin cutar ba, cirewar HCV RNA da wuya ba ya faruwa.A cikin aikin asibiti, yawancin marasa lafiya da ke fama da ciwon hanta na C suna da kyau ga anti HCV (masu cutar da marasa lafiya, irin su masu cutar HIV, masu karɓan kwayoyin halitta masu ƙarfi, marasa lafiya tare da hypogammaglobulinemia ko hemodialysis marasa lafiya na iya zama marasa kyau ga anti HCV), kuma HCV RNA na iya zama tabbatacce ko korau (matakin HCV RNA ya ragu bayan maganin rigakafi).